eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | kawasaki disease |
| Comorbidity | C0027051|myocardial infarction |
| Sentences | 5 |
| PubMedID- 24565879 | Objectives: to describe the potential for acute myocardial infarction as a complication of antecedent kawasaki disease (kd). |
| PubMedID- 20717006 | However, there are reports of the use of thrombolytic agents, including streptokinase, urokinase and tissue plasminogen activator, as well as the monoclonal platelet glycoprotein (gp)iib/iiia receptor inhibitor, abciximab, that have been used to treat myocardial infarction in children with kawasaki disease. |
| PubMedID- 25446304 | myocardial infarction associated with kawasaki disease in adult man: case report and review of literature. |
| PubMedID- 21063878 | Experience of primary percutaneous coronary intervention (pci) for young adults with acute myocardial infarction (ami) due to sequelae of kawasaki disease (kd) has been extremely limited. |
| PubMedID- 21120463 | This study determined the long-term outcome for patients after myocardial infarction (mi) due to kawasaki disease (kd). |
Page: 1